Page last updated: 2024-09-04

sk&f 83959 and ecopipam

sk&f 83959 has been researched along with ecopipam in 2 studies

Compound Research Comparison

Studies
(sk&f 83959)
Trials
(sk&f 83959)
Recent Studies (post-2010)
(sk&f 83959)
Studies
(ecopipam)
Trials
(ecopipam)
Recent Studies (post-2010) (ecopipam)
940461471834

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Platt, DM; Rowlett, JK; Spealman, RD1
Bergman, J; Desai, RI; Neumeyer, JL; Nguyen, P; Paronis, CA1

Other Studies

2 other study(ies) available for sk&f 83959 and ecopipam

ArticleYear
Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Cocaine; Discrimination Learning; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Muscle Rigidity; Receptors, Dopamine D1; Saimiri

2000
Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
    European journal of pharmacology, 2007, Mar-08, Volume: 558, Issue:1-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Blinking; Conditioning, Psychological; Dopamine Agonists; Male; Receptors, Dopamine D1; Saimiri; Stereoisomerism

2007